MOLL FREDERIC H

Director Frederic H. Moll purchased 501,253 shares of SSII at $3.99 ($2.0M); 4 of 4 prior SSII buys averaged 90d return +557.6%.

Director Frederic H. Moll purchased 501,253 shares at $3.99 on 2026-03-06, bringing his total holdings to 10,775,485 shares (+4.9% vs pre-transaction). This buy occurs as the stock trades at $4.42, down 61.1% from its 52-week high of $11.35 but up 16.6% over the preceding 30 days. Most significantly, all 4 of Moll's prior open-market purchases at SSII (on 2025-02-20, 2025-01-09, 2024-12-31, and 2024-11-25) were well-timed at the 90-day mark, averaging +557.6% return. Additionally, 2 other insiders bought within the past 14 days, forming a cluster buy pattern. The company remains unprofitable (net income $-3.7M in the latest quarter) despite 105.7% annual revenue growth, and its market cap stands at $859.1M. The confluence of repeated well-timed accumulation by this director, a multi-insider cluster buy, and continued insider purchases despite near-term volatility and ongoing losses warrants attention to whether insiders are positioning ahead of a potential inflection.

Director Frederic Moll bought 20,000 PRCT shares at $39.26 on 2025-08-13 (+2.4% of holdings); stock down -30.8% over 30 days and -59.7% from 52-week high.

Frederic Moll, a director at PROCEPT BioRobotics, purchased 20,000 shares ($785.1K) in an open-market transaction, growing his stake by 2.4% to 863.2K shares. The buy occurs against a backdrop of significant recent price pressure: the stock has declined -30.8% over the past 30 days and trades -59.7% below its 52-week high of $99.45. Moll's cross-ticker track record shows strong historical outcomes on buys (4 prior acquisitions averaging +524.1% return over 30 days and +591.5% over 90 days with 100% win rate), though he has not purchased PRCT shares in the measurable history provided. The company itself is growing revenue at +64.8% annually but remains unprofitable, with latest-quarter net income of -$19.6M against $79.2M in quarterly revenue. The confluence of recent weakness and an insider purchase warrants attention to the underlying fundamentals and Moll's conviction in the company's recovery trajectory.

Director Frederic Moll buys 3,645,224 shares of SSII at $1.37 ($5.0M); holdings surge 56.8% despite company's $-6.1M net loss.

Frederic Moll, a Director, purchased 3,645,224 shares at $1.37 on 2025-02-20, the fourth consecutive open-market buy at SSII within 3 months and part of a pattern where his prior three SSII purchases (at lower prices) each generated 30-day returns of +541.4%, +559.6%, and +410.2%. His cross-ticker track record shows 3 prior buys with an average 30-day return of +503.7% and 90-day return of +628.9% with a 100% win rate, while his 10 prior sells averaged only +8.0% over 30 days and +25.9% over 90 days with a 0.00% well-timed rate. The current price of $9.70 reflects a 30-day gain of +33.8% since this transaction, consistent with his historical ability to capture upside. However, the stock trades in a highly volatile 52-week range of $0.32–$10.00, and the underlying company remains unprofitable with a $-6.1M net loss for its most recent full fiscal year, creating material uncertainty about the sustainability of recent price appreciation.

Director MOLL FREDERIC H bought 1,457,726 shares of SSII at $1.37 (2025-01-09) for $2,000,000.07; stock up +131.7% in 90 days but company lost $6,119,381.00 in FY.

Frederic H. Moll's purchase of 1,457,726 shares at $1.37 represents a $2,000,000.07 commitment from a director with prior buying activity at this ticker. The post-trade price of $8.11 reflects a +88.6% gain over 30 days and +131.7% over 90 days, significantly outpacing his cross-ticker buy average of 30-day return +410.2% from only 2 prior buys. However, context reveals material constraints: the underlying company reported net income of $-6,119,381.00 for its most recent full fiscal year, making this an insider purchase into an unprofitable enterprise despite recent sharp price appreciation. The timing of this acquisition—following a buy on 2024-12-31 and another on 2024-11-25—establishes a concentrated accumulation pattern at the same ticker; while his same-ticker buy on 2024-11-25 has achieved +410.2% in 30 days, his 0-of-0 well-timed buys at the 90-day mark across all prior trades suggests caution regarding the sustainability of recent gains. The divergence between near-term price action and negative profitability warrants attention to whether this position reflects conviction in a turnaround or exposure to operational risk.

Director Moll Frederic H bought 2,186,589 shares of SSII at $1.37 on 2024-12-31 for $3.0M, raising holdings 51.7% to 6.42M shares.

On 2024-12-31, director Moll Frederic H purchased 2,186,589 shares (2.19M shares) of SS Innovations International, Inc. at $1.37, committing $3,000,000.11 ($3.0M) to expand his stake by 51.7% to 6,415,589 shares (6.42M shares). The transaction occurred when the stock was trading near its 52-week low ($0.32–$8.50 range) and has since risen 95.0% over 30 days and 95.5% over 90 days to a current price of $7.80, suggesting the entry point captured significant near-term upside. However, the company remains unprofitable with a net income of $-6,119,381.00 ($-6.1M) over its most recent full fiscal year, raising questions about the sustainability of the stock's recent momentum. The insider's cross-ticker track record shows 1 prior buy with an average 30-day return of +410.2%, and his most recent same-ticker buy on 2024-11-25 at SSII has also returned +410.2% at 30 days, but his 10 prior sells across all tickers posted a 0.00% well-timed rate at the 90-day mark, indicating a history of selling into rallies rather than declines.

Director Moll buys 3,644,315 shares for $5.0M at $1.37 on unprofitable company, holdings surge 623.3%

Frederic H Moll, a director at SS Innovations International, Inc., purchased 3,644,315 shares for $5,000,000.18 on 2024-11-25 at $1.37 per share, bringing his holdings from 584,685 shares to 4,229,000 shares, a 623.3% increase. This represents a substantial personal capital commitment to the company. However, the company reported net income of $-6,119,381.00 over its most recent full fiscal year, meaning SSII operates at a loss. The current stock price of $3.70 is 56.5% below the 52-week high of $8.50 and down 7.5% over the past 30 days, suggesting the insider entered during a period of downward price momentum. Across all prior open-market trades in his history (cross-ticker), Moll's 10 previous sales averaged a 90-day return of +25.9% with a well-timed rate of 0.00%, indicating those sales were poorly timed—the stock rose after he exited. This purchase warrants scrutiny given the company's unprofitability and the insider's historical difficulty in executing well-timed exits.